G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/574 (2006.01) G01N 33/53 (2006.01)
Patent
CA 2761873
The present invention relates to the assessment of lung cancer. It discloses the use of protein CYBP in the assessment of lung cancer. It also relates to a method for assessing lung cancer in vitro using a liquid sample, derived from an individual by measuring CYBP in said sample. Measurement of CYBP can, e.g., be used in the early detection or in the follow-up of patients with lung cancer.
La présente invention concerne l'évaluation du cancer du poumon et l'utilisation de la protéine CYBP dans l'évaluation du cancer du poumon. L'invention concerne également un procédé d'évaluation du cancer du poumon in vitro à l'aide d'un échantillon liquide, provenant d'un individu, par la mesure de CYBP dans ledit échantillon. La mesure de CYBP peut, par exemple, être utilisée dans la détection précoce ou dans le suivi de patients atteints du cancer du poumon.
Andres Herbert
Karl Johann
Kloeckner Julia
Roessler Markus
Tacke Michael
Borden Ladner Gervais Llp
F. Hoffmann-La Roche Ag
LandOfFree
Cybp as a marker for lung cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cybp as a marker for lung cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cybp as a marker for lung cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1921517